Start by creating a safe space by showing you beleive them.
Rigor acadêmico, estilo jornalístico
Todos os artigos de Long COVID
Exibindo 61 - 80 de 125 artigos
We’ve become used to the term ‘brain fog’ in connection to long COVID. But what is it and how do you know if you have it?
How does stress impact the body’s ability to fight infection?
A new paper looks at referrals to a long COVID clinic in England over the past two years. The results are good news.
The increased risks of heart attack and stroke after COVID shown in a recent study, could drive a new pandemic of heart disease over coming years.
Since immunity from COVID vaccination begins to wane over time, it’s important that everyone, irrespective of age, receives their boosters as soon as they are eligible to do so.
We know very little about how long COVID affects the body, and why some people develop ongoing symptoms and others don’t. But emerging evidence offers clues.
As New Zealand emerges from its Omicron wave, increasing hybrid immunity and access to antivirals mean it’s time to shift the focus of COVID management.
A new study finds that misdirected immune responses can persist for months in those who are suffering from long COVID-19.
A recent study suggests one in eight people who get COVID will go on to develop long COVID.
A good doctor can help you work out when tiredness has crossed over into true fatigue.
Mainstream medicine hasn’t yet found enough evidence-based treatments for long COVID. No wonder sufferers are turning to unproven therapies.
While a strong immune response is essential to fight against viral infection, an immune system that continues to stay active long after the virus has been cleared can lead to lung damage.
Contrary to widely held beliefs, effective therapies exist for post-infection conditions like long COVID. But we’ll need to come to terms with our history to make a difference for sufferers.
Face masks are still an effective way to help stop the spread of the BA.5 subvariant.
Long COVID sufferers may have experienced a wider variety of symptoms than previously thought, new research has found.
Long COVID patients are taking desperate measures in the hope of getting better. It’s time to increase our focus on testing potential long COVID treatments in clinical trials.
SARS-CoV-2 is not the first virus to cause unexplained chronic illness, but the sheer size of this pandemic means more people will develop long COVID.
People who are vaccinated are less likely to get long COVID, with lower rates of symptoms reported among those who have had their booster.
A new study has analysed UK data from long-term health surveys and electronic health records to understand how common long COVID is, and who might be at higher risk.
Principais colaboradores
-
Professor of Public Health, University of Southampton
-
Associate Professor, Department of Public Health, University of Otago
-
Professor, Research Centre for Hauora and Health, Massey University
-
Research Fellow, Faculty of Health Sciences, Curtin University, and The Perron Institute for Neurological and Translational Science, Curtin University
-
Professor of Public Health, University of Otago
-
Research Fellow, The University of Western Australia
-
Associate Professor and Chief Health Officer - COVID and Health Emergencies, Burnet Institute
-
Conjoint Professor, School of Medicine and Public Health, University of Newcastle
-
Professor of Genomic Epidemiology and Hon Consultant Rheumatologist, King's College London
-
SHARP Professor, Vitalities Lab, Centre for Social Research in Health and Social Policy Centre, and the ARC Centre of Excellence for Automated Decision-Making and Society, UNSW Sydney
-
Associate Professor, Child and Adolescent Health, University of Sydney
-
Associate Professor, Texas A&M University
-
Associate Professor, Division of Infectious Diseases, Department of Medicine, McMaster University
-
Associate Clinical Professor, Institute of Applied Health Research, University of Birmingham
-
Professor of Health Studies, University of Westminster
